Isotechnika Reports First Quarter 2013 Financial Results GlobeNewswire (press release) A combined company, having both the lupus nephritis and renal transplantation indications under a single corporate umbrella, would likely offer the most commercially attractive opportunity. Subsequent to March 31, 2013, the Company entered into two ... |
